Showing results (441-450 of 591) with videos related to
Sort By:
Pageof 60
Proceedings of the National Academy of Sciences of the United States of America|December 20, 1994
Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinantsK Kitamura, E Stockert, P Garin-Chesa, et al.Cancer Immunity|May 16, 2003
Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expressionM J Scanlan, I Gout, C M Gordon, et al.Cancer Immunity|August 27, 2009
Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancerNana E Tchabo, Paulette Mhawech-Fauceglia, Otavia L Caballero, et al.Proceedings of the National Academy of Sciences of the United States of America|July 11, 2003
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responsesSacha Gnjatic, Djordje Atanackovic, Elke Jäger, et al.Cancer Immunity|December 17, 2004
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clonesEduardo Huarte, Julia Karbach, Sacha Gnjatic, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, A M Scott, C R Divgi, et al.International Journal of Cancer|October 15, 1982
Serological response of melanoma patients receiving melanoma cell vaccines. I. Autologous cultured melanoma cellsP O Livingston, T Watanabe, H Shiku, et al.Journal of Clinical Immunology|September 13, 2006
Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin contentSheng-Wei Ye, Yu Wang, Danila Valmori, et al.Blood|April 1, 1994
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicityP C Caron, J G Jurcic, A M Scott, et al.Cancer Research|June 19, 2001
Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor gradeT Kurashige, Y Noguchi, T Saika, et al.Pageof 60